Screener
Royalty Pharma RPRX Interest Payable Current
Interest Payable Current at other companies
Other financials
Where this comes from
Reported directly by Royalty Pharma in its filing.
Tagged under the XBRL concept us-gaap:InterestPayableCurrent.
The source filing: Royalty Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:02 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001802768-26-000015
FAQ
- What is Royalty Pharma's interest payable current?
- Royalty Pharma (RPRX) reported interest payable current of $107.77M in Q2 2026.
- How has Royalty Pharma's interest payable current changed year-over-year?
- Royalty Pharma's interest payable current increased by 25.9% year-over-year, from $85.61M to $107.77M.
- What is the long-term trend for Royalty Pharma's interest payable current?
- Over 5 years (2020 to 2025), Royalty Pharma's interest payable current has grown at a 21.3% compound annual growth rate (CAGR), from $42.15M to $110.82M.
- What does interest payable current mean?
- Interest Payable Current as reported by Royalty Pharma plc Class A Ordinary Shares.
Ask your AI about Royalty Pharma's interest payable current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude